课题基金 / 基金详情

Establishment of personal protection method for life-style diseases : type IV hyperlipoproteinemia as a model case

Establishment of personal protection method for life-style diseases : type IV hyperlipoproteinemia as a model case
生活方式病个体防护方法的建立——以IV型高脂蛋白血症为典型病例
批准号:
11670402
负责人:
TAKAGI Atsuko
金额:
$1.86万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

TAKAGI Atsuko的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The aim of this study is to establish individual methods of prevention for life-style-related diseases, especially hypertriglyceridemia as a model case, because we think it is practical to focus on an individual genetical weakness for prevention against life-style-related diseases. We have elucidated etiology of primary type IV hyperlipidemia is a genetic background of heterozygous lipoprotein lipase (LPL) deficiency and superimposing triglyceride synthesis-stimulating factor on its genetic background. It means a LPL heterozygous deficient person without triglyceride synthesis-stimulating factor doesn't manifest hypertriglyceridemia. Individuals with heterozygous LPL deficiency have to be more carefully of superimposition of triglyceride synthesis-stimulating factor, alcohol drinking for example, than persons with two alleles of a normal LPL gene. The reliable and accurate genetic diagnosis of heterozygous LPL aberration is needed for development of individual methods of prevention for … More hypertiglyceridemia. We developed and improved LPL and hepatic triglyceride lipase mass measurement methods, direct sequencing of LPL gene, PCR method which didn't overlook mutations, and hypertriglyceride-induced atherogenic small dense LDL detection method. On the basis of these developments, we accumulated LPL gene mutations in Japanese. From the subjects with low LPL mass values, Y61X, G188E, D204E, Int3-3' c(-6)t, G154V, G105R, Int8-5' t(2)c mutations were detected. These missense mutations were confirmed to lead non-functional LPL production with COS-1 in vitro-expression system. As the Int3-3' c(-6)t mutation didn't have an aberrant splicing product in vivo and in vitro, this mutation seemed to link to another mutation which led to LPL deficiency. The Int8-5' t(2)c mutation led to the utilization of a cryptic 5' donor splice site in exon8 as an alternative splice site, skipping of a 134-bp fragment of exon8. These technical developments and improvements, and an accumulation of LPL mutations would contribute to LPL gene diagnosis that makes individual methods of prevention for hypertriglyceridemia possible. Less
期刊论文(45)
专著(0)
科研奖励(0)
会议论文
Tamazawa, N.: "Identification of homozygous lipoprotein lipase gene mutation in a woman with recurrent aggravation of hypertriglyceridemia induced by pregnancy (in Japanese)"The Lipid. 11. 79-84 (2000)
Tamazawa, N.:“妊娠引起的高甘油三酯血症反复加重的女性中纯合脂蛋白脂肪酶基因突变的鉴定(日语)”The Lipid。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kimura, H.: "Development and evaluation of a direct sandwich enzyme-linked immunosorbent assay for the quantification of lipoprotein lipase mass in human plasma."Clinical Biochemistry. 32. 15-23 (1999)
Kimura, H.:“用于定量人血浆中脂蛋白脂肪酶质量的直接夹心酶联免疫吸附测定的开发和评估。”临床生物化学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Mori A: "Improved method for direct DNA sequencing of the lipoprotein lipase gene using a DNA autosequencer"Clin Biochem. 33. 323-327 (2000)
Mori A:“使用 DNA 自动测序仪对脂蛋白脂肪酶基因进行直接 DNA 测序的改进方法”Clin Biochem。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
池田康行: "家族性高コレステロール血症 In:先天異常症候群辞典(黒木良和 編)"日本臨床. (印刷中). (2001)
Yasuyuki Ikeda:“家族性高胆固醇血症:先天性异常综合征词典(由 Yoshikazu Kuroki 编辑)”日本临床(2001 年出版)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
40
    Development and its application of the comprehensive analysis system to hypertriglyceridemia: mainly on nongenetic factors
    Development and the application of a comprehensive cause-analysis system for hypertriglyceridemia that is a risk factor for coronary heart disease
    Development and application of “Catching-whole-mutations-in-genome method" that aims at health promotion activity
    Elucidation of an underlying etiology of atherogenic type IV hyperlipoproteinemia and development of its genetic diagnostic method
    海外基金